Vehbi Koç Foundation American Hospital, known locally as Amerikan Hastanesi, is a non-profit private hospital located in the Nişantaşı area of Istanbul, Turkey. The hospital was founded in 1920 by Mark Lambert Bristol, Rear Admiral in the US Navy, and was initially subsidized by the American Red Cross.

There are 278 beds in Amerikan Hastanesi.

During the past decade, Amerikan Hastanesi conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Amerikan Hastanesi" are "Bankart Lesions" (1 trials), "Prostatectomy" (1 trials), "Shoulder Pain" (1 trials) and "Supraspinatus Tendinitis" (1 trials). Many other conditions were trialed in "Amerikan Hastanesi" in a lesser frequency.

Most popular intervention types in "Amerikan Hastanesi" are "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Robotic prostatectomy" (1 trials) and "anterior supra scapular nerve block" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amerikan Hastanesi" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Amerikan Hastanesi". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Amerikan Hastanesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Amerikan Hastanesi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".